EMERGENT BIOSOLUT (ER4 BE) stock market data APIs
€8.818
0(0%)
as of November 6, 2025
Try our APIs with
free plan!
EMERGENT BIOSOLUT Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ER4.BE.
Prev. Close
8.818
Open
8.818
High
8.818
Low
8.818
52 wk Range
3.77-11.19
Market Cap
1 908 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EMERGENT BIOSOLUT data using free add-ons & libraries
Get EMERGENT BIOSOLUT Fundamental Data
EMERGENT BIOSOLUT Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-29
- EPS/Forecast: 0.11
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EMERGENT BIOSOLUT News
New
Emergent BioSolutions (EBS) Is Up 28.1% After Strong Q3 Results and Raised 2025 Guidance Has the Bull Case Changed?
Emergent BioSolutions recently reported strong third-quarter 2025 results, with revenue of US$231.1 million and net income of US$51.2 million, and raised its full-year guidance for both revenue and ne...
Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out?
Shares of Emergent Biosolutions (EBS) have been strong performers lately, with the stock up 39.7% over the past month. The stock hit a new 52-week high of $13.41 in the previous session. Emergent Bios...
Emergent BioSolutions Inc (EBS) Q3 2025 Earnings Call Highlights: Surpassing Revenue ...
This article first appeared on GuruFocus. Revenue: $231 million for Q3 2025, exceeding the guidance range of $180 million to $210 million. Adjusted EBITDA Margin: 38% for Q3 2025. Net Income: $51 mil...
Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates
Emergent Biosolutions (EBS) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of a loss of $0.12 per share. This compares to earnings of $1.37 per share a year ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
